Current FDA directives for promoting public health

Area of Science:

• Public Health Policy
• Drug Regulation and Evaluation
• Healthcare System Efficiency

Background:

• The Reagan Administration's FDA operates on a philosophy of shared responsibility between the private sector and government for healthcare efficiency.
• The FDA recognizes that assuring a supply of safe and effective drugs requires more than its own efforts, necessitating innovation and collaboration.

Purpose of the Study:

• To outline the current directions and underlying philosophy of the Food and Drug Administration (FDA).
• To describe the FDA's initiatives in regulatory review and drug evaluation.
• To highlight the shared responsibility in public health protection.

Main Methods:

• Comprehensive reviews of FDA regulations and the drug-evaluation process.
• Description of the pilot program for patient package inserts.
• Analysis of responses from a public hearing on the patient package insert program.

Main Results:

• The FDA is actively reviewing regulations and the drug evaluation process to enhance efficiency.
• Hospital pharmacists play a crucial role in maximizing drug benefits via pharmacy and therapeutics committees.
• Public response to the patient package insert pilot program indicates a shared understanding of public health responsibility.

Conclusions:

• Effective public health protection is a shared responsibility among government, health professions, industry, and the public.
• Improving communication and collaboration between the FDA and pharmacy is essential for successful public health initiatives.
• Innovative science and technology are vital for new drug development and ensuring maximum benefit with minimal harm.